Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01093 CSPC PHARMA
RT Nominal down4.770 -0.010 (-0.209%)
石藥集團有限公司
CSPC PHARMACEUTICAL GROUP LIMITED
Financial Year (D/M)01/01 - 31/12
Listing Date21/06/1994
Listing Price (HKD)1.050
Market Cap (HKD)55.631 Billions
Shares Capital
Issued Share Capital11,638,301,732
Market Value Indicator (Latest)
Year (Currency)2024/06 - Interim (RMB)
EPS (RMB)25.510 cts
DPS (RMB)14.648 cts
Divpayout Ratio (%)57.423%
Cashflowper Share ($)--
BNV (RMB)2.930 dollar
Market Value Indicator (Year)
Peratio8.9
Yield (%)6.276
Pricetobook Ratio1.586
Remarks:  Real time quote last updated: 30/12/2024 12:03
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service.
Security Code
Company Name (Chi/Eng/Keywords)
Industry
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.